五礦資源(01208.HK)去年銅鋅產量分別跌15%及3%
五礦資源(01208.HK)公布,去年銅及鋅的總產量分別為38.46萬噸及24.51萬噸,按年跌15%及3%。
公司指,各礦山的運營表現良好,因此銅、鋅及鉛產量較第三季度增加,而Las Bambas的採礦量、Kinsevere的選礦量以及Dugald River的金屬產量及回收率均創新高。Dugald River鋅及鉛的全年產量也均創新高。
公司期望,於今年將生產銅36萬至39萬噸,以及鋅24萬至26萬噸,預期Las Bambas的銅產量將由2022年起恢復正常,2022至2025年預計年平均產量約為40萬噸。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.